Request Information

You are requesting information on:
Tasrif Pharmaceutical Granted Second US Patent For CD155-Targeting Antibody Developed With Abzena's Humanization Immunogenicity Platforms
Abzena

Already a member of Bioprocess Online or VertMarkets? Sign in now.

E-mail

First Name

Last Name

Job Title

Job Function

Company

Phone

Address

City

State

Country

Zip/Postal Code

Save my information

Why?

In order for our suppliers to better serve your request, please enter specific requirements or questions below:

Additional Information